Clinical Trial: Clinical Efficacy and Safety of Teriparatide Combined with Jintiange Capsule in Patients with Low-Turnover Severe Osteoporosis and Very High Fracture Risk (China)

Posted On: 2026-08-13

China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Efficacy and Safety of Teriparatide Combined with Jintiange Capsule in Patients with Low-Turnover Severe Osteoporosis and Very High Fracture Risk'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130017

Registration Time: 2026/08/13

Type: Interventional study

Primary Sponsor: The People,s Hospital of Nanchuan,Chongqing

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333318

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical Efficacy and Safety of Teriparatide Combined with Jintiange Capsule in Patients with Low-Turnover Severe Osteoporosis and Very High Fracture Risk (China)